[ZVRA] QoQ Quarter Result on 31-Mar-2023 [#Q1]

Stock
[ZVRA] Zevra Therapeutics, Inc.
Announcement Date
31-Mar-2023
Financial Year
2023
Quarter
31-Mar-2023 [#Q1]
Profit Trend
QoQ- -30.44%
YoY- -531.28%
Quarter Report
ZVRA's Result
ZVRA's Financial Summary
View:
Show?
Quarter Result
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
Revenue 13,217 2,895 8,470 2,879 2,319 2,874 1,300 367.33%
PBT -15,153 -13,868 -5,158 -11,870 -9,055 -6,649 -24,757 -27.84%
Tax 0 177 -74 -103 -34 -33 -715 -
NP -15,153 -14,045 -5,084 -11,767 -9,021 -6,616 -24,042 -26.42%
Tax Rate - - - - - - - -
Total Cost 28,370 16,940 13,554 14,646 11,340 9,490 25,342 7.79%
Ratio Analysis
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
NP Margin -114.65 -485.15 -60.02 -408.72 -389.00 -230.20 -1,849.38 -84.25%
Per Share
31/12/23 30/09/23 30/06/23 31/03/23 31/12/22 30/09/22 30/06/22 CAGR
EPS -0.40 -0.40 -0.15 -0.34 -0.26 -0.19 -0.70 -31.06%
EPS Diluted -0.40 -0.40 -0.15 -0.34 -0.26 -0.19 -0.70 -31.06%

PBT = Profit before Tax, NP = Net Profit, NP Margin = Net Profit Margin, EPS = Earning Per Share, EPS Diluted = Earning Per Share Diluted.

NP Margin, QoQ ⃤ & YoY ⃤ figures in Percentage; EPS & EPS Diluted figures in Cent.

All figures in '000 unless specified.